Your browser doesn't support javascript.
loading
Spectrum of Bacterial Colonization in Patients Hospitalized for Treatment of Multidrug-Resistant Tuberculosis.
Annear, Dale; Gaida, Razia; Myburg, Kierra; Black, John; Truter, Ilse; Bamford, Colleen; Govender, Sharlene.
Afiliação
  • Annear D; Department of Biochemistry and Microbiology, Nelson Mandela University, Port Elizabeth, South Africa.
  • Gaida R; Drug Utilization Research Unit (DURU), Department of Pharmacy, Nelson Mandela University, Port Elizabeth, South Africa.
  • Myburg K; Department of Biochemistry and Microbiology, Nelson Mandela University, Port Elizabeth, South Africa.
  • Black J; Drug Utilization Research Unit (DURU), Department of Pharmacy, Nelson Mandela University, Port Elizabeth, South Africa.
  • Truter I; Department of Medicine, Livingstone Hospital, Eastern Cape Department of Health, Port Elizabeth, South Africa.
  • Bamford C; Drug Utilization Research Unit (DURU), Department of Pharmacy, Nelson Mandela University, Port Elizabeth, South Africa.
  • Govender S; National Health Laboratory Service, Groote Schuur Hospital Microbiology Laboratory, Cape Town, South Africa.
Microb Drug Resist ; 27(5): 691-697, 2021 May.
Article em En | MEDLINE | ID: mdl-33074767
ABSTRACT
This study investigated the bacterial colonization in patients admitted for treatment of drug-resistant tuberculosis in a specialized TB hospital. Identification and antimicrobial susceptibility testing of bacterial isolates (n = 62) from nasal, groin, and rectal swabs [patient cohort (n = 37)] were determined by the VITEK-MS system. Resistance gene analysis was by PCR and DNA sequencing. Molecular typing of Klebsiella pneumoniae isolates was by Multilocus Sequencing Typing (MLST). Patients (n = 13/37; 35%) were colonized by multidrug-resistant (MDR) bacteria (ESBL and MRSA) on admission. Of the 24 patients who were not colonized by MDR bacteria on admission, 46% (17/37) became colonized by MDR bacteria within 1 month of admission, mostly with ESBL-producing Enterobacteriales and resistance to aminoglycosides and fluoroquinolones. ESBL Escherichia coli (41/62; 66%) and K. pneumoniae (14/62; 23%) predominated. Genes encoding for ESBLs (blaCTX-M-14, blaCTX-M-15, blaSHV-28, blaOXA-1, and blaOXY-2) and plasmid-mediated quinolone resistant genes (qnrB1, qnrB4, and qnrB10) were detected. MLST revealed genetic diversity among the K. pneumoniae isolates from hospitalized patients. This study provides insight into bacterial pathogen colonization in hospitalized TB patients with the first occurrence of the qnrB4 and qnrB10 genes and co-expression of genes qnrB4+aac(6')-lb-cr, qnrB10+aac(6')-lb-cr, qnrB4+qnrS1, and qnrB10+qnrS1 in fluoroquinolone-resistant E. coli isolates within South Africa. However, the source and colonization routes of these isolates could not be determined.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Infecções por Bactérias Gram-Negativas / Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Infecções por Bactérias Gram-Negativas / Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article